CW70239

General

Cell Line

hPSCreg name CIRMi438-A
Cite as:
CIRMi438-A (RRID:CVCL_DM49)
Alternative name(s)
CW70239
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
CIRMi357-A
(CW70124)
Donor diseases:
type 2 diabetes mellitus
CIRMi379-A
(CW70158)
Donor diseases:
type 2 diabetes mellitus
CIRMi386-A
(CW70170)
Donor diseases:
type 2 diabetes mellitus
CIRMi387-A
(CW70171)
Donor diseases:
type 2 diabetes mellitus
CIRMi414-A
(CW70201)
Donor diseases:
type 2 diabetes mellitus
CIRMi437-A
(CW70235)
Donor diseases:
type 2 diabetes mellitus
CIRMi458-A
(CW70261)
Donor diseases:
type 2 diabetes mellitus
CIRMi471-A
(CW70276)
Donor diseases:
type 2 diabetes mellitus
CIRMi472-A
(CW70278)
Donor diseases:
type 2 diabetes mellitus
CIRMi473-A
(CW70279)
Donor diseases:
type 2 diabetes mellitus
CIRMi485-A
(CW70297)
Donor diseases:
type 2 diabetes mellitus
CIRMi487-A
(CW70299)
Donor diseases:
type 2 diabetes mellitus
CIRMi152-A
(CW50068)
Donor diseases:
type 2 diabetes mellitus
CIRMi493-A
(CW70306)
Donor diseases:
type 2 diabetes mellitus
CIRMi494-A
(CW70307)
Donor diseases:
type 2 diabetes mellitus
CIRMi497-A
(CW70310)
Donor diseases:
type 2 diabetes mellitus
CIRMi515-A
(CW70337)
Donor diseases:
type 2 diabetes mellitus
CIRMi518-A
(CW70341)
Donor diseases:
type 2 diabetes mellitus
CIRMi522-A
(CW70345)
Donor diseases:
type 2 diabetes mellitus
CIRMi183-A
(CW50118)
Donor diseases:
type 2 diabetes mellitus
CIRMi268-A
(CW70002)
Donor diseases:
type 2 diabetes mellitus
CIRMi527-A
(CW70351)
Donor diseases:
type 2 diabetes mellitus
CIRMi529-A
(CW70354)
Donor diseases:
type 2 diabetes mellitus
CIRMi533-A
(CW70359)
Donor diseases:
type 2 diabetes mellitus
CIRMi280-A
(CW70016)
Donor diseases:
type 2 diabetes mellitus
CIRMi535-A
(CW70364)
Donor diseases:
type 2 diabetes mellitus
CIRMi289-A
(CW70032)
Donor diseases:
type 2 diabetes mellitus
CIRMi290-A
(CW70033)
Donor diseases:
type 2 diabetes mellitus
CIRMi301-A
(CW70044)
Donor diseases:
type 2 diabetes mellitus
CIRMi303-A
(CW70047)
Donor diseases:
type 2 diabetes mellitus
CIRMi304-A
(CW70048)
Donor diseases:
type 2 diabetes mellitus
CIRMi306-A
(CW70050)
Donor diseases:
type 2 diabetes mellitus
CIRMi309-A
(CW70057)
Donor diseases:
type 2 diabetes mellitus
CIRMi337-A
(CW70101)
Donor diseases:
type 2 diabetes mellitus
CIRMi390-A
(CW70174)
Donor diseases:
type 2 diabetes mellitus
CIRMi391-A
(CW70175)
Donor diseases:
type 2 diabetes mellitus
CIRMi400-A
(CW70080)
Donor diseases:
type 2 diabetes mellitus
CIRMi434-A
(CW70230)
Donor diseases:
type 2 diabetes mellitus
CIRMi452-A
(CW70255)
Donor diseases:
type 2 diabetes mellitus
CIRMi454-A
(CW70257)
Donor diseases:
type 2 diabetes mellitus
CIRMi121-A
(CW50033)
Donor diseases:
type 2 diabetes mellitus
CIRMi465-A
(CW70269)
Donor diseases:
type 2 diabetes mellitus
CIRMi466-A
(CW70270)
Donor diseases:
type 2 diabetes mellitus
CIRMi467-A
(CW70272)
Donor diseases:
type 2 diabetes mellitus
CIRMi470-A
(CW70275)
Donor diseases:
type 2 diabetes mellitus
CIRMi475-A
(CW70281)
Donor diseases:
type 2 diabetes mellitus
CIRMi136-A
(CW50050)
Donor diseases:
type 2 diabetes mellitus
CIRMi477-A
(CW70283)
Donor diseases:
type 2 diabetes mellitus
CIRMi478-A
(CW70284)
Donor diseases:
type 2 diabetes mellitus
CIRMi486-A
(CW70298)
Donor diseases:
type 2 diabetes mellitus
Last update 12th June 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator California Institute for Regenerative Medicine (CIRM)
Owner California Institute for Regenerative Medicine (CIRM)
Distributors
Derivation country United States

External Databases

BioSamples SAMEA113594312
Cellosaurus CVCL_DM49
Wikidata Q54816934

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: allowed

Donor Information

General Donor Information

Sex female
Age of donor (at collection) 65-69

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
DIABETIC, NO RETINOPATHY - DIABETES TYPE II
Synonyms
  • NIDDM
  • T2DM - type 2 diabetes mellitus
  • adult onset diabetes
  • adult-onset diabetes
  • diabetes mellitis type 2
  • diabetes mellitis type II
  • diabetes mellitus, noninsulin-dependent
  • diabetes mellitus, noninsulin-dependent, association with
  • diabetes mellitus, noninsulin-dependent, late onset
  • diabetes mellitus, type 2
  • diabetes mellitus, type II
  • diabetes, type 2
  • insulin resistance, severe, digenic
  • non-insulin dependent diabetes
  • non-insulin dependent diabetes mellitus
  • non-insulin-dependent diabetes mellitus
  • noninsulin dependent diabetes
  • noninsulin-dependent diabetes mellitus
  • type 2 diabetes
  • type 2 diabetes mellitus
  • type 2 diabetes mellitus non-insulin dependent
  • type II diabetes
  • type II diabetes mellitus
  • diabetes mellitus, noninsulin-dependent, 2
  • diabetes mellitus, non-insulin-dependent, susceptibility to
  • diabetes mellitus, noninsulin-dependent, susceptibility to
  • diabetes mellitus, type 2, protection against
  • diabetes mellitus, type 2, susceptibility to
  • diabetes mellitus, type II, susceptibility to
  • hypertension, insulin resistance-related, susceptibility to
  • insulin resistance, susceptibility to
  • maturity-onset diabetes
  • type 2 diabetes mellitus, susceptibility to
  • T2D
  • T2DM
show more synonyms

External Databases (Donor)

BioSamples SAMEA113594313

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Please provide contact information of the holder of the original Donor Information Sheet. info@cirm.ca.gov
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Please provide the contact information info@cirm.ca.gov
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? UC San Diego
Approval number #140090
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? UC San Diego
Approval number #140090
Is there an MTA available for the cell line? Yes

hIPSC Derivation

General

Source cell type
A cell found predominately in the blood.
Age of donor (at collection) 65-69

Reprogramming method

Vector type Non-integrating
Vector Episomal
Is reprogramming vector detectable?
No

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium Essential 8™

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
NANOG
Yes
Lin28
Yes
Undifferentiated cells were analyzed by proprietary assays approved by California Institute of Regenerative Medicine (CIRM) as described in the attached publication. Pluripotency of established iPSC cultures were tested by qPCR on bulk samples using 48 genes including standard pluripotency genes (listed above). Samples were assigned a passing score after analysis with a non-supervised classifier based on an appropriate sample set. (Novak, T. 2015. Drug Discovery World pp. 47-53.)
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
Mesoderm
Ont Id: UBERON_0000926
Ectoderm
Ont Id: UBERON_0000924

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
Normal

Other Genotyping (Cell Line)